French Top Stock Picks from Analysts

Edenred

Market Cap: €4.1b

Operates as a digital platform for services and payments for companies, employees, and merchants worldwide.

Teleperformance

Market Cap: €3.1b

Operates as a digital business services company in France and internationally.

SEB

Market Cap: €2.5b

Designs, manufactures, and markets small domestic equipment in Western Europe, rest of Europe, the Middle East, Africa, North and South America, China, and rest of Asia.

Vusion

Market Cap: €2.2b

Engages in the provision of digitalization solutions for commerce in Europe, Asia, and North America.

Pluxee

Market Cap: €1.6b

Offers employee benefits and engagement solutions services in France, Latin America, Continental Europe, and internationally.

Ipsos

Market Cap: €1.5b

Through its subsidiaries, provides survey-based research services for companies and institutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Inventiva

Market Cap: €999.1m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.

MedinCell

Market Cap: €764.0m

A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.

Valneva

Market Cap: €691.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Ubisoft Entertainment

Market Cap: €633.6m

Produces, publishes, distributes, and operates video games for consoles, PC, smartphones, and tablets in both physical and digital formats in Europe, North America, and internationally.

Worldline

Market Cap: €405.2m

Provides payments and transactional services for financial institutions, merchants, corporations, and government agencies in Northern Europe, Central and Eastern Europe, Southern Europe, and internationally.

Aramis Group SAS

Market Cap: €377.5m

Engages in the online sale of used vehicles in France, Belgium, the United Kingdom, Austria, Italy, and Spain.

Genfit

Market Cap: €281.3m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Transgene

Market Cap: €251.4m

A biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.

Cellectis

Market Cap: €236.1m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Sidetrade

Market Cap: €213.2m

Operates as a SaaS company in France and internationally.

Groupe Partouche

Market Cap: €172.7m

Through its subsidiaries, operates casinos, hotels, restaurants, dancehalls, leisure facilities, and bars in France, other European countries, and internationally.

Bastide Le Confort Médical

Market Cap: €170.3m

Engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy.

Arverne Group

Market Cap: €170.2m

Produces and sells geothermal energy in France.

Median Technologies

Market Cap: €158.8m

Engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally.

Fountaine Pajot

Market Cap: €156.8m

Designs, develops, produces, and sells sailing catamarans, motor catamarans, and monohull for recreational boating markets internationally.

Innate Pharma

Market Cap: €145.6m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

NSE

Market Cap: €140.5m

Designs, produces, and sells integrated systems for civil and military in France and internationally.

Deezer

Market Cap: €135.2m

Provides music, lossless HiFi audio, and industry defining features on a scalable platform in France, Germany, the United Kingdom, Brazil, the United States, and internationally.

ABIONYX Pharma

Market Cap: €135.1m

A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.

MaaT Pharma

Market Cap: €123.7m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Adocia

Market Cap: €118.0m

A clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.

Sensorion

Market Cap: €112.6m

A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.

Compagnie Lebon

Market Cap: €111.6m

Engages in the hotel, private equity, real estate, and thermal bath businesses in France.

Pullup Entertainment Société anonyme

Market Cap: €108.7m

Develops, publishes, and distributes games in France, the United States, Europe, the Middle East, Africa, Asia, and internationally.

OSE Immunotherapeutics

Market Cap: €108.0m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

AB Science

Market Cap: €101.4m

A clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.

Reworld Media Société Anonyme

Market Cap: €100.8m

Engages in the thematic media business in France.

Crossject Société Anonyme

Market Cap: €99.6m

Develops needle-free injection systems in France.

Affluent Medical

Market Cap: €78.7m

A medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France.

AFYREN SAS

Market Cap: €78.6m

Provides biobased products to replace petroleum-based molecules in France.